<DOC>
	<DOC>NCT01251146</DOC>
	<brief_summary>This is a Phase 4, prospective, multi-centric and randomized controlled study to compare the effects of bisoprolol and atenolol on resting heart rate (RHR) and sympathetic nervous system's (SNS) activity in subjects with essential hypertension.</brief_summary>
	<brief_title>A Randomized Controlled Study to Assess the Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Subjects With Essential Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<mesh_term>Bisoprolol</mesh_term>
	<criteria>Subjects aged between 2565 years Subjects with essential hypertension (EH) Subjects with systolic blood pressure (SBP) 140160 millimeter of mercury (mmHg) and diastolic blood pressure (DBP) 90100 mmHg Subjects with normal sinus rhythm Subjects with resting heart rate (RHR) greater than 70 bpm Subjects who give written informed consent Subjects with atrial fibrillation (AF)/sick sinus syndrome (SSS)/atrioventricular block IIIII Grade (AVB IIIII) without pacemaker Subjects with bradyarrhythmia/hypotension Subjects with unstable angina pectoris (UAP)/acute myocardial infarction (AMI)/heart failure (HF) (New York Heart Association [NYHA] Class III IV) Subjects with uncontrolled diabetes mellitus (DM) Subjects with bronchial asthma Subjects with gastrointestinal ulcer or skin ulcer Subjects with liver dysfunction/renal impairment Subjects treated with calcium channel blockers (except amlodipine) or other betablockers. Subjects with glaucoma Subjects with known allergic/intolerance to betablocker Pregnant or lactating women Subjects who had participated in another clinical study within the last 3 months Subjects who have legal incapacity or limited legal capacity</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Bisoprolol</keyword>
	<keyword>Atenolol</keyword>
</DOC>